We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Glenmark Pharmaceuticals Seeks Rehearing on Tarka Patent Ruling
Glenmark Pharmaceuticals Seeks Rehearing on Tarka Patent Ruling
Generic firm Glenmark Pharmaceuticals wants a federal appeals court to rehear its case over rights to the combination hypertension drug Tarka, arguing that an April decision was invalid because it incorrectly attributed exclusive patent rights.